{{Rsnum
|rsid=3218005
|Gene=CDKN2BAS
|Chromosome=9
|position=22000248
|Orientation=minus
|GMAF=0.1579
|Gene_s=CDKN2B-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 83.1 | 15.4 | 1.5
| HCB | 62.2 | 37.8 | 0.0
| JPT | 59.1 | 31.8 | 9.1
| YRI | 57.1 | 39.7 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 62.2 | 37.8 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs3218005]] shows an association with [[breast cancer]] in a British study involving ~2300 patients. The odds ratio for the (G;G) vs (A;A) homozygotes is 1.55 (CI: 1.02-2.37, p=0.013).{{PMID|18174243|OA=1
}}

{{PMID|17459456|OA=1
}} A common variant of the p16(INK4a) genetic region is associated with physical function in older people.

{{PMID|19258477|OA=1
}} Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.

{{PMID|20386740|OA=1
}} Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}